loadpatents
Patent applications and USPTO patent grants for Osborne; Barbara.The latest application filed is for "exopolysaccharide for inflammatory disease".
Patent | Date |
---|---|
Exopolysaccharide for inflammatory disease Grant 10,383,888 - Osborne , et al. A | 2019-08-20 |
Exopolysaccharide For Inflammatory Disease App 20160317566 - Osborne; Barbara ;   et al. | 2016-11-03 |
Transgenic ungulates capable of human antibody production Grant 7,803,981 - Robl , et al. September 28, 2 | 2010-09-28 |
Transgenic bovines capable of human antibody production Grant 7,414,170 - Robl , et al. August 19, 2 | 2008-08-19 |
Transgenic ungulates capable of human antibody production App 20080040821 - Robl; James M. ;   et al. | 2008-02-14 |
Fluid-absorbing products comprising superabsorbent material in a water-soluble pouch and methods of using the same App 20060173430 - Lee; Baosheng ;   et al. | 2006-08-03 |
NCAGE Code | 4C8K6 | OSBORNE BARBARA |
CAGE Code | 4C8K6 | OSBORNE, BARBARA |
DUNS | 621823637 | OSBORNE, BARBARA |
SEC | 0001300447 | Osborne Barbara |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.